Aristides M - Search Results

1

Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study.

Davey PJ, Schulz M, Gliksman M, Dobson M, Aristides M, Stephens NG. Davey PJ, et al. Among authors: aristides m. Am J Cardiol. 1998 Aug 15;82(4):414-7. doi: 10.1016/s0002-9149(98)00354-3. Am J Cardiol. 1998. PMID: 9723625 Clinical Trial.

2

Cost-effectiveness of pergolide compared to bromocriptine in the treatment of Parkinson's disease: a decision-analytic model.

Davey P, Rajan N, Lees M, Aristides M. Davey P, et al. Among authors: aristides m. Value Health. 2001 Jul-Aug;4(4):308-15. doi: 10.1046/j.1524-4733.2001.44039.x. Value Health. 2001. PMID: 11705298 Free article.

3

Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients.

Aristides M, Gliksman M, Rajan N, Davey P. Aristides M, et al. Heart. 1998 Jan;79(1):12-7. doi: 10.1136/hrt.79.1.12. Heart. 1998. PMID: 9505912 Free PMC article.

4

Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach.

Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Dobson M. Davey P, et al. Among authors: aristides m. Pharmacoeconomics. 1998 Mar;13(3):347-58. doi: 10.2165/00019053-199813030-00009. Pharmacoeconomics. 1998. PMID: 10178660

5

Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis.

Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Gliksman M. Davey P, et al. Among authors: aristides m. Clin Ther. 1997 Jul-Aug;19(4):656-74. doi: 10.1016/s0149-2918(97)80091-4. Clin Ther. 1997. PMID: 9377611

6

Murmurs from the heart (or why the stethoscope is not an economic tool).

Aristides M, Gliksman M. Aristides M, et al. Heart. 1998 Jan;79(1):10-1. doi: 10.1136/hrt.79.1.10. Heart. 1998. PMID: 9518073 Free PMC article. No abstract available.

7

Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal Cancer.

Aristides M, Chen J, Schulz M, Williamson E, Clarke S, Grant K. Aristides M, et al. Pharmacoeconomics. 2002;20(11):775-84. doi: 10.2165/00019053-200220110-00006. Pharmacoeconomics. 2002. PMID: 12201796

8

Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance.

Benrimoj SI, Langford JH, Berry G, Collins D, Lauchlan R, Stewart K, Aristides M, Dobson M. Benrimoj SI, et al. Among authors: aristides m. Pharmacoeconomics. 2000 Nov;18(5):459-68. doi: 10.2165/00019053-200018050-00005. Pharmacoeconomics. 2000. PMID: 11151399 Clinical Trial.

9

Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer.

Lees M, Aristides M, Maniadakis N, McKendrick J, Botwood N, Stephenson D. Lees M, et al. Among authors: aristides m. Pharmacoeconomics. 2002;20(5):325-37. doi: 10.2165/00019053-200220050-00004. Pharmacoeconomics. 2002. PMID: 11994042 Clinical Trial.

10

Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK.

Aristides M, Lees M, Botwood N, McKendrick J, Stephenson DA, Maniadakis N. Aristides M, et al. Eur J Health Econ. 2003 Sep;4(3):216-21. doi: 10.1007/s10198-003-0173-6. Epub 2003 Jul 1. Eur J Health Econ. 2003. PMID: 15609188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters